PPARγ is a member of the nuclear receptor superfamily and is activated by endogenous fatty acids as well as synthetic thiazolidinediones, such as pioglitazone and rosiglitazone, which have demonstrated clinical efficacy in treating diabetes primarily through their actions in adipose tissues [16]. The gene discussed is PPARG; the disease is diabetes mellitus.